TITLE:
Hepatocellular Carcinoma in Chad: A Retrospective Study of 219 Cases
AUTHORS:
Ali Mahamat Moussa, Pascal Pineau, Mayanna Habkreo, Gumbo Nedjim, Tahir Mahamat Saleh, Adoum Abderrazak Fouda, Mahamat Ali Hachim, Adawaye Chatté, Bessimbaye Nadlaou, Moussa Kalli, Choua Ouchemi
KEYWORDS:
Chad, Middle Africa, Hepatocellular Carcinoma, Hepatitis Viruses, Alcohol, Idiopathic
JOURNAL NAME:
Open Journal of Gastroenterology,
Vol.13 No.11,
November
30,
2023
ABSTRACT: Background: Although hepatocellular carcinoma was historically considered an important scourge in Middle Africa, there is no publication describing this disease in Chad. Methods: We conducted a retrospective analysis of 219 patients with hepatocellular carcinoma (HCC) attending care at the University Reference Hospital of Ndjamena between 2007 and 2016. Results: This series of HCC was characterized by a male predominance (M:F = 2.4) with a mean tumor onset at the end of the fifth decade of life (49.9 ± 14.7 years). Tumors appear on a cirrhotic liver in 70% of cases and were already multifocal at diagnosis in two thirds of the patients. Alpha-fetoprotein was above the physiological threshold (10 ng/mL) in 73.4% of cases measured and above the so-called diagnostic level (400 ng/mL) in 53.4% of patients. The principal risk factor was chronic infection with hepatitis B virus, detected in 52.6% of cases. Patients seropositive for hepatitis C virus were infrequent (8.6%) and heavy alcohol intake was even less prevalent (5.9%). Remarkably, a very large subset of patients did not present any infectious or lifestyle risk factor (43.4%). Mean AFP values or fibrosis assessment scores are usually lower in these patients than in HBV-infected ones. Conclusions: The etiological spectrum of HCC is far from being fully established in Chad. Further epidemiological research is warranted to identify risk factors involved in a large proportion of cases. Exposure to aflatoxin B1 and dysmetabolic conditions affecting the liver have to be investigated as priority.